SynthesisNeurosurgical review2026
Spontaneous obliteration of cerebral arteriovenous malformations: a meta-analysis of incidence and angioarchitectural correlates.
Synthesis in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous angiographic obliteration of brain arteriovenous malformations (SpOAVM) is rare, and published incidence estimates are limited by heterogeneous denominators and variable imaging follow-up. We performed a meta-analysis to estimate the incidence of SpOAVM and to describe associated angioarchitectural features. Literature from 1974 to January 2026 was systematically reviewed in accordance with PRISMA. Observational studies reporting complete spontaneous angiographic obliteration of intracranial arteriovenous malformations (AVMs), without prior AVM-directed therapy, were included. The meta-analysis used a linear mixed model with a rare-event-appropriate log-log link. Denominator definition, imaging modality, follow-up duration, reappearance after apparent obliteration, and angioarchitectural variables were extracted. Nine studies contributed 47 eligible SpOAVMs across 7,922 brain AVMs, although some denominators were mixed or estimated. In four cohorts with definitive no-intervention denominators, pooled SpOAVM incidence was 1.93% (95% confidence interval [CI], 1.04-3.44), corresponding to 0.39 per 100 person-years. Across all eligible studies, including cohorts with uncertain denominator purity, the pooled estimate was 1.08% (95% CI, 0.58-3.05). SpOAVMs most commonly followed hemorrhage (37/45, 82%). Exploratory external-cohort comparisons showed that SpOAVMs had a higher proportion of smaller nidus size and single venous drainage. Reappearance after apparent obliteration was reported in 2/35 cases. SpOAVM is rare and occurs far less frequently than hemorrhage during untreated follow-up. Apparent obliteration requires cautious interpretation because imaging modality and follow-up were heterogeneous. Standardized prospective angiographic surveillance is needed to define clinically relevant subgroups.
Indexed as
Identifiers
42557466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.